Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations
Clinical trial NCT02643329 · COMPLETED
Trial details
- NCT number
- NCT02643329
- Sponsor
- Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2016-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.